NCT00707850: Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection |
|
|
| Completed | 4 | 300 | RoW | PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin), Peginterferon Alfa-2a (40KD) plus COPEGUS | Baqiyatallah Medical Sciences University, Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Tehran Hepatitis Center, Guilan University of Medical Sciences, Tabriz Research Center for Gastroenterology and Liver Diseases | Hepatitis C, Thalassemia | 09/09 | 09/09 | | |
NCT00056862: Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 |
|
|
| Completed | 4 | 58 | US | Peginterferon alfa-2a, Pegasys, Ribavirin, Copegus | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Hepatitis C | 01/10 | 06/10 | | |
